购物车
- 全部删除
- 您的购物车当前为空
Mibavademab 是一种人源化抗体,由CHO表达,并靶向LEPR/CD295。其包含huIgG4SP型重链和huκ型轻链,预测分子量 (MW) 为145.58 kDa。有关Mibavademab的同型对照,可参考Human IgG4 kappa, Isotype Control。
Mibavademab 是一种人源化抗体,由CHO表达,并靶向LEPR/CD295。其包含huIgG4SP型重链和huκ型轻链,预测分子量 (MW) 为145.58 kDa。有关Mibavademab的同型对照,可参考Human IgG4 kappa, Isotype Control。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | 待询 | 期货 | |
5 mg | 待询 | 期货 |
产品描述 | Mibavademab is a CHO-expressed humanized antibody targeting LEPR/CD295. It comprises a huIgG4SP heavy chain and a huκ light chain, with an estimated molecular weight (MW) of 145.58 kDa. For its isotype control, please refer to HumanIgG4kappa, Isotype Control. |
存储 | store at low temperature | store at -20°C | Shipping with blue ice. |
评论内容